| | |
Per share and
accompanying warrant |
| |
Per pre-funded
warrant and accompanying warrant |
| |
Total
|
| |||||||||
Offering price | | | | $ | 4.90 | | | | | $ | 4.8999 | | | | | $ | 204,997,450 | | |
Placement agent fees(1) | | | | $ | 0.2205 | | | | | $ | 0.2205 | | | | | $ | 9,224,885 | | |
转至学者岩石控股公司,未计费用 | | | | $ | 4.6795 | | | | | $ | 4.6794 | | | | | $ | 195,772,565 | | |
| | |
S-Page
|
| |||
About this prospectus
|
| | | | S-ii | | |
Prospectus summary
|
| | | | S-1 | | |
Risk factors
|
| | | | S-16 | | |
有关前瞻性陈述的告诫声明
|
| | | | S-19 | | |
Use of proceeds
|
| | | | S-21 | | |
Dividend policy
|
| | | | S-22 | | |
Capitalization
|
| | | | S-23 | | |
Dilution
|
| | | | S-24 | | |
提供的证券说明
|
| | | | S-26 | | |
某些美国联邦所得税考虑因素
|
| | | | S-29 | | |
Plan of distribution
|
| | | | S-36 | | |
Legal matters
|
| | | | S-38 | | |
Experts
|
| | | | S-38 | | |
您可以在哪里找到更多信息
|
| | | | S-38 | | |
通过引用并入某些信息
|
| | | | S-38 | | |
| | |
Page
|
| |||
About this prospectus
|
| | | | 1 | | |
Risk factors
|
| | | | 2 | | |
有关前瞻性陈述的告诫声明
|
| | | | 3 | | |
The company
|
| | | | 5 | | |
Use of proceeds
|
| | | | 7 | | |
Securities we may offer
|
| | | | 8 | | |
股本说明
|
| | | | 9 | | |
债务证券说明
|
| | | | 16 | | |
认股权证说明
|
| | | | 30 | | |
Description of units
|
| | | | 31 | | |
Plan of distribution
|
| | | | 34 | | |
Legal matters
|
| | | | 37 | | |
Experts
|
| | | | 37 | | |
您可以在哪里找到更多信息
|
| | | | 37 | | |
引用注册成立
|
| | | | 37 | | |
| | |
12-Month data
|
| |
24-Month data
pooled non- ambulatory pts |
| |
24-Month data
*excluding pts w/scoliosis surgery |
|
HFMSE与基线的平均变化(95%CI)
|
| |
3.6 points
(95% CI: 1.2, 6.0) N=32 |
| |
4.0 points
(95% CI: 1.5, 6.5) N=29 |
| |
4.4 points
(95% CI: 2.0, 6.9) N=28 |
|
RULM中基线的平均变化
(95% CI) |
| |
1.3 points
(95% CI: 0.2, 2.3) N=31 |
| |
1.9 points
(95% CI: 0.8, 3.0) N=33 |
| |
2.3 points
(95% CI: 1.2, 3.4) N=30 |
|
| | |
As of March 31, 2022
|
| |||||||||
(千为单位,共享数据除外)
|
| |
Actual
|
| |
As adjusted
|
| ||||||
现金、现金等价物和有价证券
|
| | | $ | 210,211 | | | | | $ | 405,655 | | |
长期负债总额
|
| | | | 61,288 | | | | | | 61,288 | | |
优先股,面值0.001美元;授权、实际和调整后的10,000,000股,没有已发行和已发行的股票,实际和调整后的
|
| | | | 0 | | | | | | 0 | | |
普通股,面值0.001美元;授权股份150,000,000股,实际和调整后为35,300,823股;已发行和已发行股份51,627,353股,调整后为51,627,353股
|
| | | | 35 | | | | | | 51 | | |
新增实收资本
|
| | | | 555,513 | | | | | | 750,941 | | |
累计其他综合收益(亏损)
|
| | | | (152) | | | | | | (152) | | |
Accumulated deficit
|
| | | | (384,080) | | | | | | (384,080) | | |
股东权益总额
|
| | | | 171,316 | | | | | | 366,760 | | |
Total capitalization
|
| | | $ | 232,604 | | | | | $ | 428,048 | | |
|
每股公开发行价和配套普通股认股权证
|
| | | | | | | | | $ | 4.90 | | |
|
截至2022年3月31日的每股有形账面净值
|
| | | $ | 4.85 | | | | | | | | |
|
可归因于此次发行的预计每股有形账面净值增加
|
| | | $ | 2.25 | | | | | | | | |
|
本次发售生效后的调整后每股有形账面净值的预计值
|
| | | | | | | | | $ | 7.10 | | |
|
参与此次发行的投资者每股有形账面净值增加
|
| | | | | | | | | $ | 2.20 | | |
|
| | |
PER SHARE AND
ACCOMPANYING WARRANT |
| |
PER PRE-FUNDED
WARRANT AND ACCOMPANYING WARRANT |
| |
TOTAL
|
| |||||||||
Offering price
|
| | | $ | 4.90 | | | | | $ | 4.8999 | | | | | $ | 204,997,450 | | |
Placement agent fees
|
| | | $ | 0.2205 | | | | | $ | 0.2205 | | | | | $ | 9,224,885 | | |
未扣除费用的收益,归我们所有
|
| | | $ | 4.6795 | | | | | $ | 4.6794 | | | | | $ | 195,772,565 | | |
| | |
Page
|
| |||
About this Prospectus
|
| | | | 1 | | |
Risk Factors
|
| | | | 2 | | |
有关前瞻性陈述的告诫声明
|
| | | | 3 | | |
The Company
|
| | | | 5 | | |
Use of Proceeds
|
| | | | 7 | | |
Securities We May Offer
|
| | | | 8 | | |
股本说明
|
| | | | 9 | | |
债务证券说明
|
| | | | 16 | | |
认股权证说明
|
| | | | 30 | | |
Description of Units
|
| | | | 31 | | |
Plan of Distribution
|
| | | | 34 | | |
Legal Matters
|
| | | | 37 | | |
Experts
|
| | | | 37 | | |
您可以在哪里找到更多信息
|
| | | | 37 | | |
引用注册成立
|
| | | | 37 | | |
| J.P. Morgan | | |
Piper Sandler
|
|